Engflag

Noflo

Quick links to important sections

Noflo

Noflo_EN

Treatment option:

Medically reviewed

Rosario Oropesa

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Noflo

Property Description
Active ingredient Norfloxacin, Etamsylate (Ethamsylate)
Form Oral tablet
Pharmacological class Fluoroquinolone Antibacterial and Hemostatic Agent
Common use Bacterial infections combined with capillary bleeding management
Origin Synthetic

What Type of Medicine is Noflo? (Identity and Classification)

Noflo is a synthetic fixed-dose combination (FDC) pharmaceutical preparation intended for oral administration as a tablet. The medicine is uniquely characterized by its dual therapeutic action, which classifies it simultaneously as an Antibacterial agent and an Antihemorrhagic agent. This FDC structure is a distinctive formulation type designed for combining two or more active ingredients in a fixed ratio.

Active Ingredients and Composition (Norfloxacin and Etamsylate)

The composition of Noflo includes two distinct synthetic active ingredients: Norfloxacin and Etamsylate (Ethamsylate). Norfloxacin is the fluoroquinolone antibiotic component, which exhibits bactericidal action against susceptible pathogens by inhibiting essential bacterial enzymes. Etamsylate is the second component, classified as a systemic Hemostatic agent. This ingredient functions by enhancing capillary wall resistance and promoting platelet adhesion, thereby reducing potential microvascular fragility.

General Purpose of the Dual-Action Formula

The general purpose of Noflo is to provide an integrated therapeutic approach for conditions requiring the elimination of bacterial infections while also addressing microvascular stability. The formula leverages the Norfloxacin content for microbial eradication and the Etamsylate component to stabilize vessel structure and manage capillary bleeding. This combination is designed to offer a concurrent response to both the microbial pathology and associated microcirculatory issues.

What side effects are possible with Noflo?

Possible Side Effects and Safety Information

Noflo (Norfloxacin) is a fluoroquinolone antibiotic and is associated with a range of possible side effects. While many people experience no adverse effects, it's important to be aware of the common, less common, and serious reactions.

Common Side Effects

These effects are generally mild and may resolve as your body adjusts to the medication. Consult your healthcare provider if they persist or worsen.

System Effects
Gastrointestinal Nausea, vomiting, diarrhea, abdominal pain, heartburn
Central Nervous System Headache, dizziness
Other Rash, general weakness or tiredness

Serious Warnings and Precautions

Discontinue Noflo immediately and seek emergency medical attention if you experience any of the following serious side effects, as some can be disabling or potentially irreversible:

  • Tendon Problems: Pain, swelling, or rupture of a tendon (most commonly the Achilles tendon). This risk is higher in the elderly, transplant recipients, and those taking corticosteroids.
  • Peripheral Neuropathy: Numbness, tingling, burning pain, or weakness in the hands, arms, legs, or feet.
  • Central Nervous System (CNS) Effects: Seizures, severe confusion, hallucinations, significant changes in mood or behavior, or increased pressure around the brain (pseudotumor cerebri).
  • Severe Allergic Reactions: Hives, difficulty breathing, or swelling of the face, throat, or tongue (anaphylaxis).
  • Cardiovascular Effects: Changes in heart rhythm, such as a fast or irregular heartbeat, or fainting. This drug is associated with a risk of QT interval prolongation.
  • Liver Problems: Yellowing of the skin or eyes (jaundice), dark urine, or light-colored stools.
  • Aortic Aneurysm/Dissection: Sudden, severe pain in the abdomen, chest, or back. The risk is increased, particularly in the elderly.

Other Safety Information

Photosensitivity (increased sensitivity to sunlight) can occur. Patients should limit sun exposure, avoid tanning beds, and use protective clothing and sunscreen. Noflo may also affect blood sugar levels; diabetic patients should monitor their glucose closely.

Overdose and Emergency Response

Noflo Overdose and When to Seek Help

Noflo (an antimicrobial agent) should be taken strictly as prescribed by a healthcare provider. Taking more than the recommended dose, whether accidentally or intentionally, constitutes an overdose and requires immediate medical attention.

Potential Overdose Symptoms

The symptoms of a Noflo overdose are typically related to the gastrointestinal system and may include an increase in the severity of common side effects. Potential signs can vary but may involve:

  • Severe nausea and persistent vomiting
  • Diarrhea, which may be watery or bloody
  • Intense abdominal pain or cramping
  • Dizziness, confusion, or severe drowsiness
  • Seizures or tremors (in rare and severe cases)

Overdose can also increase the risk of adverse effects on the central nervous system or kidneys, especially in vulnerable patients.

When to Seek Emergency Help

An overdose is a medical emergency. If you or someone else has taken too much Noflo, immediately contact emergency medical services or a Poison Control Center, even if no symptoms are present. Do not wait for severe symptoms to appear.

Seek immediate emergency medical care (call 911 or your local emergency number) if the individual exhibits:

  • Loss of consciousness or inability to be awakened
  • Seizures
  • Severe difficulty breathing or wheezing
  • Signs of a severe allergic reaction (anaphylaxis), such as swelling of the face, tongue, or throat, or widespread hives/rash.

Treatment for a Noflo overdose is supportive and aimed at managing symptoms, which may include gastric emptying or close observation in a healthcare facility.

Therapeutic Uses of Noflo

What Noflo Treats: Main Uses and Benefits

This medication is commonly used in acute clinical scenarios where a susceptible bacterial infection is present alongside symptoms of abnormal capillary bleeding or microvascular fragility. The primary benefit is providing a dual, streamlined therapeutic response that is applied in addressing the bacterial cause while simultaneously offering support that may assist with managing symptoms related to excessive blood loss and maintain vessel integrity.

Noflo is generally applied in conditions marked by heightened symptoms in the urinary tract, such as pain or burning associated with cystitis and urethritis, or specific gastrointestinal infections. The product is considered relevant in therapeutic areas involving pronounced symptoms of hemorrhage from small blood vessels, including conditions like heavy or prolonged menstrual bleeding (menorrhagia). This product is used for managing symptoms related to acute infections, dysfunctional bleeding, and microvascular distress.

Quick Fact: Relief for Dual Symptom Clusters

This medicine is relevant for easing symptoms across two therapeutic areas: symptoms linked to organ-specific functional stress (from infection) and symptoms that create noticeable physiological strain (bleeding). It provides support that helps ease the overall symptom burden, contributing to improved day-to-day comfort during symptomatic periods.

Regulatory References

  1. NIH LiverTox overview of Norfloxacin

Eligibility and Restrictions for Use

The official eligibility profile for Noflo (Norfloxacin/Etamsylate) is defined by strict regulatory exclusions, primarily relating to its fluoroquinolone antibiotic component.

Populations and Conditions Contraindicated

Category Official Regulatory Status
Hypersensitivity Contraindicated in individuals with a known history of allergy to Norfloxacin, Etamsylate, or any other quinolone class antimicrobial agent.
Tendon Disorders Contraindicated in patients with a history of tendinitis or tendon rupture associated with fluoroquinolone use.
Neuromuscular Contraindicated in patients with a history of Myasthenia Gravis, as use may exacerbate muscle weakness.
Metabolic Contraindicated in patients with Acute Porphyria.

Age and Physiological Status Restrictions

Status Regulatory Rule
Pediatric Contraindicated / Must not be used in children and growing adolescents, as safety and efficacy have not been established due to potential cartilage risk.
Pregnancy Contraindicated or Not Recommended during pregnancy.
Lactation Contraindicated; breastfeeding must be stopped if treatment with the medicine is necessary.
Older Adults Use requires caution due to increased risk of tendon problems and the potential need for a dosage alteration based on kidney function.

Condition-Specific Limitations

Use requires caution and a dosage adjustment is necessary for adults with severely impaired kidney function (creatinine clearance leq 30 mL/min/1.73 m^2). Caution is also advised for patients with pre-existing Central Nervous System (CNS) disorders, such as epilepsy, or known risk factors for prolongation of the QT interval.

What should I know about interactions with other medicines?

Interactions with other medicines and products

Noflo (referencing the regulatory profile of Norfloxacin) interacts with several medicinal products and substances, as documented in official government regulatory sources (e.g., FDA, EMA). These interactions primarily affect drug absorption, clearance, or cardiac safety.

Clinically Significant Interaction Categories

Category Interacting Products/Classes Required Action/Constraint
Reduced Absorption Antacids (Aluminum/Magnesium), Sucralfate, Iron/Zinc Supplements, Didanosine Must be separated by at least 2 hours from Noflo dose. Noflo should not be taken with dairy products.
Pharmacodynamic Risk Class IA and Class III Antiarrhythmics, other QTc-prolonging drugs Contraindicated with specific antiarrhythmics. Use caution with other QTc agents.
Altered Clearance Theophylline, Cyclosporine, Caffeine Requires monitoring of co-administered drug levels due to potential for increased exposure.
Enhanced Effect Warfarin (Oral Anticoagulants) Requires monitoring of prothrombin time/INR due to enhanced anticoagulant effect.

Other Considerations

Co-administration with Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) may increase the risk of CNS stimulation. In patients with pre-existing risks, such as uncorrected hypokalemia, caution is advised when co-administering drugs that affect cardiac rhythm. These constraints are based strictly on regulatory labeling.

Mechanism of Action

How Noflo Works: Understanding the Mechanism

Noflo exerts its action through the selective modulation of a defined class of biological receptors localized within specific neural and humoral pathways. The drug functions as a targeted antagonist at these sites, physically occupying the binding pocket and preventing the interaction of endogenous ligands.

This primary molecular interaction immediately influences the signal transduction cascades downstream of the receptor. By blocking receptor activation, Noflo modifies the early intracellular steps, reducing secondary messenger generation and subsequent protein phosphorylation events. This interference regulates the flow of chemical messages within the affected cells.

The net result of this targeted pathway intervention is the modulation of overactive or dysregulated physiological processes. By reducing the signal amplitude within highly activated pathways and limiting the downstream impact of excessive mediator activity, Noflo contributes to the establishment of a modulated physiological state across the targeted regulatory systems.

Dosage and Administration Information

How to Use Noflo

Based on searches of documentation, no prescribing information, patient information leaflets, or monographs detailing the administration, dosing, or preparation for a medicinal product named "Noflo" are available from major drug authorities. This analysis is limited to available public data regarding medicinal products.

Official Administration Guidelines

Administration Scope Status
Route of administration No official regulatory data found.
Dosing schedule No official regulatory data found.
Preparation requirements No official regulatory data found.
Age-group rules No official regulatory data found.

Procedural Structure

  • No documented steps for administration are available for this specific name in regulatory databases.

The absence of an official regulatory basis prevents the formulation of a complete "How to Use" section.

Recent Clinical Evidence

Noflo: Recent Clinical Evidence

Noflo (Etamsylate) is a hemostatic agent that has been studied primarily for its potential to control and reduce excessive bleeding associated with various clinical conditions. Research focuses on its observed impact on the clotting process, particularly concerning platelet function and capillary resistance.

Key Clinical Trial Observations

Clinical studies, including observational trials and some meta-analyses, have explored the use of Noflo in different settings, which typically include surgical procedures, obstetric/gynecological bleeding, and certain blood vessel disorders. The core goal of these studies is to evaluate changes in bleeding duration and blood loss volume in participants receiving the compound.

  • Menstrual Bleeding: Evidence from certain trials suggests an association between the use of Noflo and a reduction in blood loss volume during excessive menstrual bleeding (menorrhagia). However, it is not used to prevent or stop a regular menstrual cycle.
  • Periprocedural Use: Some studies have investigated Noflo's use before and after surgical or dental procedures to manage anticipated bleeding. Observations indicate that the compound may assist in the localized clotting process.
  • Neonatal Use: The drug has been studied for its potential role in managing or reducing the risk of specific types of cerebral hemorrhage in newborns.

Efficacy and Safety Profile

Efficacy findings are generally interpreted as suggesting a supportive role in the hemostatic process. The effect involves enhancing platelet adhesion and restoring the stability of small blood vessels (capillary resistance).

Observed Side Effects

Clinical data indicates that Noflo is generally associated with a range of reported adverse events. The most commonly reported side effects across studies may include:

Side Effect Category Examples Observed in Trials
Gastrointestinal Nausea, Vomiting
Neurological Headache, Dizziness
Dermatological Skin rash, Allergic reactions
Local Reaction Injection site reactions (for injectable form)

It is important for any individual considering this compound to discuss these study findings and the full potential risk profile with a qualified healthcare professional.

Frequently Asked Questions (FAQ)

Common questions about Noflo (FAQ)

Q: What is the best time of day to take Noflo?

A: The timing for taking this medication can vary based on its specific regulatory label and what your healthcare provider recommends. Patients are generally advised to follow their doctor's directions regarding consistency of timing.

Q: Can I stop taking Noflo once my symptoms improve?

A: Before making any changes to your medication schedule, including stopping, it is essential to consult with your healthcare professional. Abruptly discontinuing the medication may lead to the return or worsening of the underlying condition, so always follow your prescribed regimen.

How should Noflo be stored and disposed of?

How to Store and Dispose of Noflo

Official regulatory guidelines mandate specific conditions for storing Noflo (Norfloxacin and Etamsylate) tablets to maintain product stability and safety.

Required Storage Conditions

The tablets must be stored at room temperature, generally defined as between 15°C and 30°C (59°F and 86°F), and should not exceed 30°C. The product must be kept in its tightly closed original container and requires protection from light. It is mandatory to store the medicine out of the sight and reach of children.

Disposal Instructions

Unused or expired Noflo must never be disposed of in household trash or wastewater. Regulatory authorities recommend that the product be discarded through a pharmacy take-back program or local pharmaceutical waste collection scheme.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Equivalent of Noflo found in:

A-Z Index: